Developing a novel therapeutic for the rare disease Creatine Transporter Deficiency, an inborn error of metabolism
- Year invested 2014
- Investment Stage Early
- Sectors
- Investment Status Current
- Associated Team
- Website lumos-pharma.com
- Company Status Acquired (by NewLink Genetics)